[HTML][HTML] Stable gastric pentadecapeptide BPC 157, Robert's stomach cytoprotection/adaptive cytoprotection/organoprotection, and Selye's stress coping response …

P Sikiric, KB Hahm, AB Blagaic, A Tvrdeic… - Gut and liver, 2020 - ncbi.nlm.nih.gov
We reviewed again the significance of the stable gastric pentadecapeptide BPC 157 as a
likely mediator of Robert's stomach cytoprotection/adaptive cytoprotection and …

Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator

P Sikiric, S Seiwerth, L Brcic, M Sever… - Current …, 2010 - ingentaconnect.com
The significance of cytoprotection and adaptive cytoprotection and the peptides importance
remained to be not completely determined. BPC 157 is an anti-ulcer peptidergic agent …

Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157. Vascular recruitment and gastrointestinal tract healing

P Sikiric, R Rucman, B Turkovic… - Current …, 2018 - ingentaconnect.com
Years ago, we revealed a novel cytoprotective mediator, stable gastric pentadecapeptide
BPC 157, particular anti-ulcer peptide that heals different organs lesions when given as a …

Stress in gastrointestinal tract and stable gastric pentadecapeptide BPC 157. Finally, do we have a solution?

P Sikiric, S Seiwerth, R Rucman… - Current …, 2017 - ingentaconnect.com
Selye's syndrome produced by diverse nocuous agents and “response to damage as such”
means Selye's stress triad in stress coping response to reestablish homeostasis. Logically …

BPC 157 rescued NSAID-cytotoxicity via stabilizing intestinal permeability and enhancing cytoprotection

JM Park, HJ Lee, P Sikiric… - Current pharmaceutical …, 2020 - ingentaconnect.com
The stable gastric pentadecapeptide BPC 157 protects stomach cells, maintains gastric
integrity against various noxious agents such as alcohol, nonsteroidal anti-inflammatory …

[HTML][HTML] Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and …

P Sikiric, A Skrtic, S Gojkovic, I Krezic… - World journal of …, 2022 - ncbi.nlm.nih.gov
The stable gastric pentadecapeptide BPC 157 counteracts various venous occlusion-
induced syndromes. Summarized are all these arguments, in the Robert's cytoprotection …

Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress

V Jagic, B Turkovic, I Rotkvic, S Mise… - Digestive diseases and …, 1997 - Springer
Since superior protection against differentgastrointestinal and liver lesions and
antiinflammatoryand analgesic activities were noted for pentadecapeptideBPC (an essential …

Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and …

P Sikiric, S Seiwerth, L Brcic, AB Blagaic, I Zoricic… - …, 2006 - Springer
Gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, MW 1419, safe in clinical trials
for inflammatory bowel disease (PL 10, PLD 116, PLD 14736, Pliva, Croatia)) has a …

Stable gastric pentadecapeptide BPC 157: Prompt particular activation of collateral pathways

P Sikiric, S Gojkovic, M Knezevic… - Current medicinal …, 2023 - ingentaconnect.com
[3-17]. Progressive venous and arterial thrombosis, both peripherally and centrally (in the
Virchow causeconsequence triad, evidencing counteracted stasis and recovered …

Stable gastric pentadecapeptide BPC 157 and wound healing

S Seiwerth, M Milavic, J Vukojevic, S Gojkovic… - Frontiers in …, 2021 - frontiersin.org
Significance: The antiulcer peptide, stable gastric pentadecapeptide BPC 157 (previously
employed in ulcerative colitis and multiple sclerosis trials, no reported toxicity (LD1 not …